SCHEMBL20907562

SCHEMBL20907562

CC(C)OC(=O)[C@@](N)(CC(C)(C)C)c1ccc2c(ccc3ncnn32)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21149589 1.00 — —
SCHEMBL29640326 1.00 — —
SCHEMBL21112831 0.86 EGLN1 (0.33) —
SCHEMBL21112828 0.86 EGLN1 (0.33) —
SCHEMBL28399073 0.80 KDM4E (0.32) —
SCHEMBL21149528 0.80 KDM4E (0.32) —
SCHEMBL21148933 0.79 BRPF1 (0.41) —
SCHEMBL20908218 0.79 BRPF1 (0.41) —
SCHEMBL29640198 0.77 AAK1 (0.34) —
SCHEMBL28404125 0.71 SSTR4 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111212832-B 1-Benzyl-2-imino-4-phenyl-5-oxoimidazolidine derivatives as HIV protease inhibitors 吉利德科学公司 2023-09-15 — — CN disclosed
WO-2019075291-A1 1-BENZYL-2-IMINO-4-PHENYL-5-OXOIMIDAZOLIDINE DERIVATIVES AS HIV PROTEASE INHIBITORS GILEAD SCIENCES, INC. (US) 2019-04-18 — — WO disclosed
Send feedback